AI Article Synopsis
- - The study focused on evaluating blood donor eligibility and infectious disease screening in Latin American countries, as there was limited information available on this topic.
- - An international team created a 16-question survey and received responses from 82 blood donor institutions across 14 Latin American nations, revealing that most donor centers have a deferral rate of 5-25% primarily due to low hemoglobin and high-risk behaviors.
- - The results highlighted that while most centers performed serologic tests for infectious diseases like HIV and Hepatitis, there was a lack of uniformity in donor selection processes and screening practices throughout the region.
Article Abstract
Background And Objectives: Blood donor questionnaires are tools used to screen prospective blood donors to determine their eligibility. There are limited data regarding blood donor questionnaires and infectious disease screening of the blood supply in Latin American countries. This study aimed to survey donor centres in Latin American countries to learn more about blood donor screening and infection assessment.
Materials And Methods: An international team of transfusion medicine professionals including medical directors and supervisors who work or collaborate with Latin American donor centres, called 'Comité de Investigación en Medicina Transfusional', designed a survey (16 questions) to characterize blood donor eligibility in Latin America.
Results: Eighty-two institutions from 14 Latin American countries responded to the survey. Most donor centres (66%; 54 of 82) had a donor deferral percentage between 5% and 25%, and the most common causes of deferrals were low haemoglobin and high-risk behaviour. Most donors in blood centres were directed family donors compared with voluntary donors. Infection evaluation included mostly serologic assessment (81%; 30 of 37) for human immunodeficiency virus (HIV), Hepatitis B, Hepatitis C, Treponema pallidum and Trypanosoma cruzi rather than nucleic acid tests (5%; 2 of 37).
Conclusion: Heterogeneity exists in donor selection and infectious disease screening in Latin American countries. This survey provides valuable information to understand Latin American blood centre practices.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1111/vox.13730 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Cardio-Obstetrics Practice in Latin America: A Regional Survey of General Cardiologists.
JACC Adv
December 2024
Massachusetts General Hospital, Boston, Massachusetts, USA.
Background: Cardiovascular (CV) disease is a leading cause of death in pregnant women globally, especially in low- and middle-income countries including Latin America (LATAM), where there is lack of data on how cardiologists are trained in cardio-obstetrics (CO) and the practice patterns in the care of pregnant patients.
Objectives: The authors aimed to identify CO competency and practice patterns among LATAM general cardiologists.
Methods: An anonymous cross-sectional Google-based electronic survey was sent via email to clinical cardiologists through local American College of Cardiology chapters and CV societies.
-cigarette use among adolescents in Latin America: A systematic review of prevalence and associated factors.
Prev Med Rep
January 2025
One Health Research Group, Faculty of Medicine, Universidad de las Américas, Quito, Ecuador.
Background: Electronic cigarettes, introduced as a safer tobacco alternative, have unintentionally exposed millions of youths to nicotine and harmful chemicals. Adolescence, a key period for forming lifelong habits, has seen rising e-cigarette use, particularly in developing regions like Latin America, warranting thorough investigation.
Objective: To describe the prevalence and factors associated with e-cigarette use among adolescents in Latin America.
'Pharmacogenetics, health and ethnicity in Latin American populations' call for the "Dr José María Cantú Award 2024".
Drug Metab Pers Ther
December 2024
Red Iberoamericana de Farmacogenética y Farmacogenómica (RIBEF), Badajoz, Spain.
Multimodal Inpatient Prehabilitation Prior to Heart or Lung Transplantation in a Latin American Transplant Reference Center.
Transplant Proc
January 2025
Cardiothoracic Transplant Program, Instituto Nacional del Tórax, Santiago, Chile.
Introduction: Whether the implementation of a multimodal prehabilitation program is effective and safe for high-risk heart or lung transplantation candidates, whose condition prevents hospital discharge, is unclear.
Methods: We conducted a retrospective study at a cardiothoracic transplant center in Chile. Two cohorts of hospitalized patients listed for heart or lung transplant were studied: the first underwent traditional (historical) and nonstructured prehabilitation, and the second underwent protocol-driven multimodal prehabilitation (MP).
Serum Biomarkers of Pulmonary Damage and Risk for Progression of Rheumatoid Arthritis-Associated Interstitial Lung Disease.
J Rheumatol
January 2025
J.A. Sparks, MD, MMSc, Brigham and Women's Hospital, Division of Rheumatology, Inflammation, and Immunity and Harvard Medical School, Boston, Massachusetts, USA.
Objective: To investigate baseline and change of pulmonary damage biomarkers (serum Krebs von den Lungen 6 [KL-6], human surfactant protein D [hSP-D], and matrix metalloproteinase 7 [MMP-7]) with rheumatoid arthritis-associated interstitial lung disease (RA-ILD) progression.
Methods: In the Korean Rheumatoid Arthritis Interstitial Lung Disease (KORAIL) cohort, a prospective cohort, we enrolled patients with RA and ILD confirmed by chest computed tomography imaging and followed annually. ILD progression was defined as worsening in physiological and radiological domains of the 2022 American Thoracic Society, European Respiratory Society, Japanese Respiratory Society, and Latin American Thoracic Society guideline for progressive pulmonary fibrosis (PPF).
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!